The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients.
<h4>Introduction</h4>Sarcopenia, characterized by reduced skeletal muscle mass (RMM), is increasingly recognized as a significant factor influencing outcomes in various health conditions, including stroke. Although most studies focus on sarcopenia developing during stroke rehabilitation,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0313368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540260924391424 |
|---|---|
| author | Kyong Young Kim Seunguk Jung Eun Bin Cho Tae-Won Yang Seung Joo Kim Hyunsung Kim Sunhye Jung |
| author_facet | Kyong Young Kim Seunguk Jung Eun Bin Cho Tae-Won Yang Seung Joo Kim Hyunsung Kim Sunhye Jung |
| author_sort | Kyong Young Kim |
| collection | DOAJ |
| description | <h4>Introduction</h4>Sarcopenia, characterized by reduced skeletal muscle mass (RMM), is increasingly recognized as a significant factor influencing outcomes in various health conditions, including stroke. Although most studies focus on sarcopenia developing during stroke rehabilitation, the impact of sarcopenia present at the onset of acute ischemic stroke remains underexplored. This study aims to evaluate the effect of RMM at stroke onset on 3-month functional outcomes in acute ischemic stroke patients.<h4>Materials and methods</h4>We prospectively enrolled acute ischemic stroke patients admitted between May 2019 and December 2019. Muscle mass was accessed early during hospitalization using whole-body dual-energy X-ray absorptiometry (DXA), and patients were categorized into RMM and normal muscle mass (NMM) groups based on the Asian Working Group for Sarcopenia (AWGS) criteria. Functional outcomes at 3 months were assessed using the modified Rankin Scale (mRS), with unfavorable outcomes defined as mRS scores 2-5. Multivariable logistic regression and SHAP (Shapley Additive exPlanations) analyses were used to evaluate the independent impact of RMM on 3-months functional outcomes.<h4>Results</h4>A total of 99 patients were analyzed. The RMM group had a significantly higher prevalence of unfavorable outcomes at 3 months compared to the NMM group (p < 0.001). Patients with RMM were older and presented with more severe strokes. Multivariable analysis confirmed RMM as an independent predictor of unfavorable outcomes (adjusted OR: 8.07, 95% CI: 1.603-40.66, p = 0.011), even after adjusting for age and initial stroke severity. SHAP analysis ranked RMM as the second most influential predictor of unfavorable outcomes, following NIHSS on admission. These findings indicate that RMM not only worsens initial stroke severity but also independently hinders post-stroke recovery.<h4>Conclusions</h4>Reduced muscle mass at the onset of acute ischemic stroke is a significant, independent predictor of unfavorable outcomes at 3 months. In addition to its impact on recovery, RMM is linked to older age and more severe strokes, worsening prognosis. Maintaining muscle mass is also crucial for stroke prevention, as it supports cardiovascular health and resilience. Early identification and intervention for sarcopenia can improve recovery and reduce future stroke risk. |
| format | Article |
| id | doaj-art-8669489072a6422985b4443d4f804d8e |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-8669489072a6422985b4443d4f804d8e2025-02-05T05:31:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031336810.1371/journal.pone.0313368The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients.Kyong Young KimSeunguk JungEun Bin ChoTae-Won YangSeung Joo KimHyunsung KimSunhye Jung<h4>Introduction</h4>Sarcopenia, characterized by reduced skeletal muscle mass (RMM), is increasingly recognized as a significant factor influencing outcomes in various health conditions, including stroke. Although most studies focus on sarcopenia developing during stroke rehabilitation, the impact of sarcopenia present at the onset of acute ischemic stroke remains underexplored. This study aims to evaluate the effect of RMM at stroke onset on 3-month functional outcomes in acute ischemic stroke patients.<h4>Materials and methods</h4>We prospectively enrolled acute ischemic stroke patients admitted between May 2019 and December 2019. Muscle mass was accessed early during hospitalization using whole-body dual-energy X-ray absorptiometry (DXA), and patients were categorized into RMM and normal muscle mass (NMM) groups based on the Asian Working Group for Sarcopenia (AWGS) criteria. Functional outcomes at 3 months were assessed using the modified Rankin Scale (mRS), with unfavorable outcomes defined as mRS scores 2-5. Multivariable logistic regression and SHAP (Shapley Additive exPlanations) analyses were used to evaluate the independent impact of RMM on 3-months functional outcomes.<h4>Results</h4>A total of 99 patients were analyzed. The RMM group had a significantly higher prevalence of unfavorable outcomes at 3 months compared to the NMM group (p < 0.001). Patients with RMM were older and presented with more severe strokes. Multivariable analysis confirmed RMM as an independent predictor of unfavorable outcomes (adjusted OR: 8.07, 95% CI: 1.603-40.66, p = 0.011), even after adjusting for age and initial stroke severity. SHAP analysis ranked RMM as the second most influential predictor of unfavorable outcomes, following NIHSS on admission. These findings indicate that RMM not only worsens initial stroke severity but also independently hinders post-stroke recovery.<h4>Conclusions</h4>Reduced muscle mass at the onset of acute ischemic stroke is a significant, independent predictor of unfavorable outcomes at 3 months. In addition to its impact on recovery, RMM is linked to older age and more severe strokes, worsening prognosis. Maintaining muscle mass is also crucial for stroke prevention, as it supports cardiovascular health and resilience. Early identification and intervention for sarcopenia can improve recovery and reduce future stroke risk.https://doi.org/10.1371/journal.pone.0313368 |
| spellingShingle | Kyong Young Kim Seunguk Jung Eun Bin Cho Tae-Won Yang Seung Joo Kim Hyunsung Kim Sunhye Jung The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. PLoS ONE |
| title | The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. |
| title_full | The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. |
| title_fullStr | The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. |
| title_full_unstemmed | The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. |
| title_short | The impact of reduced skeletal muscle mass at stroke onset on 3-month functional outcomes in acute ischemic stroke patients. |
| title_sort | impact of reduced skeletal muscle mass at stroke onset on 3 month functional outcomes in acute ischemic stroke patients |
| url | https://doi.org/10.1371/journal.pone.0313368 |
| work_keys_str_mv | AT kyongyoungkim theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT seungukjung theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT eunbincho theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT taewonyang theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT seungjookim theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT hyunsungkim theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT sunhyejung theimpactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT kyongyoungkim impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT seungukjung impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT eunbincho impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT taewonyang impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT seungjookim impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT hyunsungkim impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients AT sunhyejung impactofreducedskeletalmusclemassatstrokeonseton3monthfunctionaloutcomesinacuteischemicstrokepatients |